-->

Videos & Press

FLCCC Releases

This page contains links to a selection of scientific reviews by physicians of the FLCCC Alliance and news articles that were written by members of the FLCCC team.

Reviews by FLCCC Alliance physicians regarding MATH+ and I-MASK+

December 14, 2020 | USA (JICM)
 Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19
FLCCC Alliance peer-reviewed paper published in the Journal of Intensive Care Medicine. This protocol potentially offers a life-saving approach to the management of hospitalized COVID-19 patients. The MATH+ protocol offers an inexpensive combination of medicines with well-known safety profiles based on strong physiologic rationale and an increasing clinical evidence base.
https://flccc.net/math-plus-rationale-journal-of-intensive-care-medicine-dec2020/

October 2020 | USA (FLCCC Alliance)
 Ivermectin in the Prophylaxis and Treatment of COVID-19
An FLCCC review of the emerging evidence supporting the use of ivermectin in the prophylaxis and treatment of COVID-19 (last updated Jan 12, 2021)
https://flccc.net/flccc-ivermectin-in-the-prophylaxis-and-treatment-of-covid-19/

September 25, 2020 | USA
 COVID-19: A Clinician’s Perspective
A master-class comprehensive review by Dr. Paul Marik of the most current scientific insights into the origin, replication, transmission, infectivity, pathophysiology, and treatment of COVID-19.
https://www.youtube.com/watch?v=bJZcDBTEGio

August 18, 2020 | USA (Taylor & Francis Online)
 MATH+ protocol for the treatment of SARS-CoV-2 infection: The scientific rationale
Paul E. Marik, Pierre Kory, Joseph Varon, Jose Iglesias & G. Umberto Meduri
https://flccc.net/math-protocol-for-the-treatment-of-sars-cov-2-infection-the-scientific-rationale/

Press Releases and Public Statements

April 29, 2021 | Public Statement
 Front Line COVID-19 Critical Care Alliance Statement on New Guidance on Ivermectin from the All India Institute of Medical Science
WASHINGTON, D.C. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, today praised the recent updated guidance from the All India Institute of Medical Science (AIIMS) to include ivermectin in its guidelines for the treatment of COVID-19. Read full statement

April 9, 2021 | Press Release
 Front Line COVID-19 Critical Care Alliance Statement on Recent Washington Post Story
WASHINGTON, D.C. – We appreciate the interest from the Washington Post in the use of ivermectin as a safe and effective preventative and treatment for COVID-19. However, the article published yesterday left out several key components of the complete story of how ivermectin is saving lives all over the world. These include the overwhelming amount of data on ivermectin… Read full release

March 31, 2021 | Public Statement
 FLCCC Alliance Statement on Weak Guidance on Ivermectin from the World Health Organization
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19.

March 18, 2021 | Press Release (on EIN Presswire)
Leading Experts Discuss the Latest Research on Preventing & Treating COVID-19 with Ivermectin and Call for its Immediate Global Use to End the Pandemic
A group of medical and scientific experts convened by the Front Line COVID-19 Critical Care Alliance (FLCCC) today call for action to put an end to the COVID-19 pandemic by immediately adopting policies that allow for the use of ivermectin in the prevention and treatment of COVID-19.

March 9, 2021 | Press Release
FLCCC Alliance Applauds International Group of Medical Experts’ Recognition of Ivermectin as a Safe and Effective Treatment for COVID-19
UK-based panel of leading experts publish their review of the latest research and call for the immediate global adoption of ivermectin to prevent and treat COVID-19 – e-bmc.co.uk.

March 7, 2021 | Public Statement
FLCCC Alliance Statement on Misleading FDA Guidance on Ivermectin
The FLCCC Alliance is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.

Feb 28, 2021 | Public Statement
FLCCC Alliance Response to the N.I.H. Guideline Committee Recommendation on Ivermectin use in COVID-19 dated February 11, 2021

Feb 7, 2021 | Public Statement
FLCCC Alliance Response to Merck’s Public Statements on Efficacy of Ivermectin in COVID-19
Merck’s assessments of ivermectin’s efficacy in COVID-19 are in striking contrast with the findings reported by multiple expert group’s systematic reviews from across the globe, including metaanalyses of the updated scientific literature […]

Feb 5, 2021 | Public Statement
 FLCCC Alliance Response to Dr. Kory’s Senate Testimony Removed by YouTube
YouTube removed the video link of Dr. Pierre Kory’s sworn testimony to the Senate Committee on Homeland Security and Governmental Affairs on official United States business […]

Jan 24, 2021 | Public Statement
 FLCCC Alliance Open Letter to the Investigators of the Oxford PRINCIPLE Trial on Ivermectin in COVID‑19
The FLCCC Alliance wishes to raise concerns about the proposed design of the Oxford PRINCIPLE Trial of ivermectin in COVID-19. We believe that it is an ethical imperative to provide those considering participation a truthful account of the available evidence of ivermectin’s efficacy in COVID-19 […]

Jan 17, 2021 | Public Statement
 FLCCC Alliance Response to the NIH Guideline Committee Recommendation on Ivermectin use in COVID-19 dated January 14th, 2021
The FLCCC considers the Panel’s unwillingness to provide more specific guidance in support of the use of ivermectin in COVID-19 to be severely out of alignment with the known clinical, epidemiological, and observational data. Our detailed response to the Panel’s criticism of the existing evidence base […]

Jan 15, 2021 | Press Release
 Ivermectin is Now a Treatment Option for Health Care Providers
NIH (National Institutes of Health) Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19

Jan 7, 2021 | Press Release
 FLCCC Alliance Invited to the NIH COVID-19 Treatment Guidelines Panel to Present Latest Data on Ivermectin
On January 6, 2021, our Drs. Pierre Kory and Paul Marik, founding members of the FLCCC Alliance, appeared before the National Institutes of Health COVID-19 Treatment Guidelines Panel to urge review of current data and an updated NIH guidance.

Dec 22, 2020 | Press Release
New One-page Summary of the Review on Ivermectin in COVID-19
FLCCC Alliance one-page summary of clinical trials showing large magnitude improvements in COVID-19 patients treated with Ivermectin. Related files:
Review on ivermectin in the prophylaxis and treatment of COVID-19  —  One-page Summary of the Review
Please also see our FAQ on Ivermectin in the Treatment of COVID-19

Dec 16, 2020 | Press Release
MATH+ Hospital Treatment Protocol for COVID-19 Now Published (JIC)
FLCCC Alliance peer-reviewed paper published in the Journal of Intensive Care Medicine. This protocol potentially offers a life-saving approach to the management of hospitalized COVID-19 patients.
https://flccc.net/math-plus-rationale-journal-of-intensive-care-medicine-dec2020/

Dec 8, 2020 | Press Release
Dr. Kory Testifies to Senate Committee About I-MASK+
Dr. Pierre Kory, President of the FLCCC Alliance addresses the Senate Committee on Homeland Security and Governmental Affairs looking into earlyoutpatient COVID-19 treatment.
Watch the video on our Official Testimony page

Dec 4, 2020 | Press Release
FLCCC Alliance Press Conference on Ivermectin & COVID-19 in Houston, Texas and Follow-Up Press Release
FLCCC Alliance calls on national health authorities to immediately review medical evidence showing the efficacy of ivermectin for the prevention of COVID-19 and as an early outpatient treatment.
Video documentation and additional material: Electronic Press Kit for the News Conference on Dec 4, 2020

Member articles

Jan 5, 2021 | USA [this website]
Masks! – Clearing Up the Confusion
When to wear them, when not to wear them, that is the question. An essay by Dr. Pierre Kory.

Sep 22, 2020 | USA [BMJ Open Respiratory Research]
 SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’
Pierre Kory (FLCCC Alliance) and Jeffrey P. Kanne
https://bmjopenrespres.bmj.com/content/7/1/e000724.full

July 6, 2020 | USA Today
 ICU doctors: Many more Americans need to wear N95 masks to slow COVID-19
Major newspaper editorial – Dr. Pierre Kory (FLCCC) and Dr. Paul H. Mayo on prevention in the pandemic
https://flccc.net/wp-content/uploads/2020/07/USAToday-More-of-us-need-to-wear-N95-masks.pdf

May 12, 2020 | USA
 My medical journey to find a treatment for COVID-19
Dr. Keith Berkowitz on how he discovered the FLCCC’s MATH+ Protocol and became a member of the Alliance
https://medium.com/@keith_27815/my-medical-journey-to-find-a-treatment-for-covid-19-2619ad7297ca

April 16, 2020 | USA
 We’ve cracked the COVID code. And why no one is listening.
Joyce Kamen (FLCCC Alliance media relations team) on Medium.com
https://medium.com/@joyce.kamen/weve-cracked-the-covid-19-code-and-why-no-one-is-listening-36f609edc…